First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients.

Clinical trial NCT07299409 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07299409
Sponsor: Nathalie Levasseur
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Triple Negative Breast Cancer Breast Cancer Metastatic Breast Cancer

Start date: 2025-12-01
Primary completion: 2027-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.